SPP1 and non-small cell lung carcinoma: In support of the feature selection approach, our signature includes ECM components identified as differentially regulated in non-small cell lung cancer, including osteopontin (SPP1), which has been associated with lung adenocarcinoma prognosis [79–83], but not yet specifically SqCC.